SNGX - יחס חוב להיוון בספרים soligenix.com

The debt-to-market capitalization structure demonstrates a lack of sales and the dependence of Soligenix, Inc. (SNGX) on grants, while the 0.05 level reflects the current magnitude of the burden. Government defense orders and pipeline variability mitigate the risks. Strict manufacturing biostandards and patent protection for orphan drugs serve as business safeguards, limiting competitors' market access.

Integrating ESG standards into the biotechnological operations of Soligenix, Inc. (SNGX) requires strict control over the funding of environmental initiatives. This metric assesses the ratio of total liabilities to equity, determining the level of debt load. It is critical for the investor to find a balance between financial leverage and insolvency risk. A low value confirms the stability of the capital structure. The dynamics of this relationship are reflected in the ratio of borrowed funds to book capitalization.